Several factors have been driving the market higher this year. The Federal Reserve has kept up its extraordinary efforts to stimulate the economy. And while the U.S. economy's recovery has been plodding, it has been strong enough to enable corporations to keep increasing their profits.
"It's bland, it's vanilla, but it's sweet," said John Manley, chief equity strategist at Wells Fargo Fund Management.
Despite the surge, stock prices remain reasonable compared with earnings, Manley said. Stock valuations are "not cheap, but they're not prohibitive," he said.
The ratio of stock prices to forecast earnings for S&P 500 companies is currently 15, according to data from FactSet. That's slightly below the average ratio of 16.2 over the last 15 years and far below the peak of 25 recorded in the late 1990s and early 2000s.
The S&P 500 added 7.56 points, or 0.4 percent, to 1,798.18. All 10 of the industry groups in the S&P 500 rose.
The Dow Jones industrial average gained 85.48 points, or 0.5 percent, to 15,961.70. The Nasdaq composite rose 13.23 points, or 0.3 percent, to 3,985.97.
Agilent jumped $4.39, or 8.7 percent, to $54.93. Exxon Mobil, a member of the Dow, rose $2.05, or 2.2 percent, to $95.27.
Investors may be getting more comfortable with the prospect of the Fed cutting back on its stimulus as long as the economy is also improving, said Jim Dunigan, a managing executive at PNC Wealth Management. The stock market's biggest setbacks this year have come when investors worried that Fed policy makers were close to paring their $85 billion per month in bond purchases, which are intended to keep interest rates low.
"The path of least resistance (for stocks) seems to be higher right now," Dunigan said.
In government bond trading, the yield on the 10-year note rose to 2.71 percent from 2.70 percent from Thursday. Oil was flat at $93.71 a barrel. Gold rose $1.10 to $1,287.40 an ounce.
Among other stocks making big moves
— Zulily surged in its first day as a publicly traded company. The Seattle-based online retailer of baby products jumped $15.70, or 71 percent, to $37.70.
— Vanda Pharmaceuticals soared $1.55, or 12 percent, to $14.59 after FDA advisers recommended approval for the company's potential sleep disorder drug tasimelteon.
— Western Union fell 75 cents, or 4.3 percent, to $16.70 after the money-transfer company said late Thursday that its longtime chief financial officer would step down.
Contact Steve Rothwell at http://www.Twitter.com/SteveRothwellAP